Literature DB >> 28692477

R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.

Ihsan Ekin Demir1, Carsten Jäger1, A Melissa Schlitter2, Björn Konukiewitz2, Lynne Stecher3, Stephan Schorn1, Elke Tieftrunk1, Florian Scheufele1, Lenika Calavrezos1, Rebekka Schirren1, Irene Esposito4, Wilko Weichert2, Helmut Friess1, Güralp O Ceyhan1.   

Abstract

OBJECTIVE: The aim of this study was to decipher the true importance of R0 versus R1 resection for survival in pancreatic ductal adenocarcinoma (PDAC). SUMMARY OF BACKGROUND DATA: PDAC is characterized by poor survival, even after curative resection. In many studies, R0 versus R1 does not result in different prognosis and does not affect the postoperative management.
METHODS: Pubmed, Embase, and Cochrane databases were screened for prognostic studies on the association between resection status and survival. Hazard ratios (HRs) were pooled in a meta-analysis. Furthermore, our prospective database was retrospectively screened for curative PDAC resections according to inclusion criteria (n = 254 patients) between July 2007 and October 2014.
RESULTS: In the meta-analysis, R1 was associated with a decreased overall survival [HR 1.45 (95% confidence interval, 95% CI 1.37-1.52)] and disease-free survival [HR 1.44 (1.30-1.59)] in PDAC when compared with R0. Importantly, this effect held true only for pancreatic head resection both in the meta-analysis [R0 ≥0 mm: HR 1.21 (1.05-1.39) vs R0 ≥1 mm: HR 1.66 (1.46-1.89)] and in our cohort (R0 ≥0 mm: 31.8 vs 14.5 months, P < 0.001; R0 ≥1 mm, 41.2 vs 16.8 months; P < 0.001). Moreover, R1 resections were associated with advanced tumor disease, that is, larger tumor size, lymph node metastases, and extended resections. Multivariable Cox proportional hazard model suggested G3, pN1, tumor size, and R1 (0 mm/1 mm) as independent predictors of overall survival.
CONCLUSION: Resection margin is not a valid prognostic marker in publications before 2010 due to heterogeneity of cohorts and lack of standardized histopathological examination. Within standardized pathology protocols, R-status' prognostic validity may be primarily confined to pancreatic head cancers.

Entities:  

Mesh:

Year:  2018        PMID: 28692477     DOI: 10.1097/SLA.0000000000002345

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  32 in total

1.  MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer.

Authors:  Jae Seok Bae; Jung Hoon Kim; Ijin Joo; Won Chang; Joon Koo Han
Journal:  Eur Radiol       Date:  2019-03-21       Impact factor: 5.315

2.  Tumour origin and R1 rates in pancreatic resections: towards consilience in pathology reporting.

Authors:  Munita Bal; Swapnil Rane; Sanjay Talole; Mukta Ramadwar; Kedar Deodhar; Prachi Patil; Mahesh Goel; Shailesh Shrikhande
Journal:  Virchows Arch       Date:  2018-08-08       Impact factor: 4.064

3.  Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Vincent P Groot; Georgios Gemenetzis; Alex B Blair; Roberto J Rivero-Soto; Jun Yu; Ammar A Javed; Richard A Burkhart; Inne H M Borel Rinkes; I Quintus Molenaar; John L Cameron; Matthew J Weiss; Christopher L Wolfgang; Jin He
Journal:  Ann Surg       Date:  2018-03-23       Impact factor: 12.969

4.  Surgical Outcomes of Pancreaticoduodenectomy for Pancreatic Cancer with Proximal Dorsal Jejunal Vein Involvement.

Authors:  Yuichi Hosokawa; Yuichi Nagakawa; Yatsuka Sahara; Chie Takishita; Tetsushi Nakajima; Yosuke Hijikata; Hiroaki Osakabe; Tomoki Shirota; Kazuhiro Saito; Hiroshi Yamaguchi; Keiichiro Inoue; Kenji Katsumata; Takayoshi Tsuchiya; Atsushi Sofuni; Takao Itoi; Akihiko Tsuchida
Journal:  J Gastrointest Surg       Date:  2018-03-08       Impact factor: 3.452

5.  Positive pancreatic neck margins-a telltale sign of complex biology.

Authors:  Elie Ghabi; Jin He
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

6.  Extended lymphadenectomy benefits patients with borderline resectable pancreatic head cancer-a single-center retrospective study.

Authors:  Jing Wang; Shao-Cheng Lyu; Ji-Qiao Zhu; Xian-Liang Li; Ren Lang; Qiang He
Journal:  Gland Surg       Date:  2021-10

7.  Hypovascular pancreas head adenocarcinoma: CT texture analysis for assessment of resection margin status and high-risk features.

Authors:  Ameya Kulkarni; Ivan Carrion-Martinez; Nan N Jiang; Srikanth Puttagunta; Leyo Ruo; Brandon M Meyers; Tariq Aziz; Christian B van der Pol
Journal:  Eur Radiol       Date:  2020-01-17       Impact factor: 5.315

8.  G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer.

Authors:  Masanori Oshi; Ankit Patel; Lan Le; Yoshihisa Tokumaru; Li Yan; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

Review 9.  What do surgeons need to know about the mesopancreas.

Authors:  Eduardo de Souza M Fernandes; Oliver Strobel; Camila Girão; Jose Maria A Moraes-Junior; Orlando Jorge M Torres
Journal:  Langenbecks Arch Surg       Date:  2021-06-12       Impact factor: 3.445

10.  The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial.

Authors:  Gennaro Nappo; Domenico Borzomati; Alessandro Zerbi; Paola Spaggiari; Ugo Boggi; Daniela Campani; Sławomir Mrowiec; Łukasz Liszka; Alessandro Coppola; Michela Amato; Tommasangelo Petitti; Fabio Vistoli; Marco Montorsi; Giuseppe Perrone; Roberto Coppola; Damiano Caputo
Journal:  Cancers (Basel)       Date:  2021-04-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.